X-ray diffraction (XRD) for mineral ingredients
X-ray diffraction identifies crystalline phases from the angles at which they scatter X-rays. In a magnesium chelate it is used for one question above all: is crystalline magnesium oxide present, and at what level can the method see it. The answer depends on a detection limit that has to be stated with the result.
In short
A phase-identification method that shows whether crystalline magnesium oxide is present, down to a stated detection limit.
How the measurement is made
A powdered sample is pressed into a holder and exposed to monochromatic X-rays, usually copper Kα at 1.5406 Å, while a detector scans the scattering angle. Crystalline planes that satisfy Bragg's law produce peaks at characteristic angles, and the pattern of peak positions and intensities is a fingerprint of the phases present. An amorphous material produces a broad halo instead of sharp peaks.
Magnesium oxide crystallises as periclase, with strong reflections near 42.9° and 62.3° two-theta when copper radiation is used. The chelate and the hydrate forms have their own patterns, often broader and weaker than the oxide because the crystallites are small. The oxide screen looks for those periclase peaks above the background, and a spiked sample series establishes what concentration the method can see.
Phase identification is done against a diffraction database, and quantification uses Rietveld refinement or a calibration curve built from spiked chelate. Grinding, loading pressure and preferred orientation change relative intensities, so sample preparation is part of the method. The report should state the detection limit for oxide in this matrix, not a generic figure from a textbook.
What the result proves
The method identifies crystalline phases. A lot that shows periclase peaks contains a separate crystalline magnesium oxide phase, and a lot with no periclase peaks above the stated limit has no crystalline oxide at that level. It can also confirm that the expected pattern of the chelate is present when a reference lot is available.
The detection limit is the number that decides what the result means. For a crystalline minor phase in a crystalline matrix, a practical limit is often in the low single-digit percent range, roughly 1–5% w/w, and an optimised method with a spiked calibration can reach below 1%. The limit depends on crystallinity, peak overlap, counting time and sample preparation, so it has to be quoted with the method.
Read with the magnesium assay and the glycine ratio, an XRD screen supports the identity story: the elemental content fits the chelate, the ligand ratio fits, and no crystalline oxide is visible. That combination is stronger than any one of the three results. It is still a combination of evidence rather than a single proof.
What it cannot tell you
Absence of peaks is not proof of absence. Amorphous or nanocrystalline magnesium oxide, and oxide particles below the detection limit, produce no clear pattern, so a few percent can be present in a lot that passes the screen. The method cannot quantify what it cannot see, and it cannot certify a material as oxide-free.
The chelate itself is often poorly crystalline, so XRD may not quantify how much chelate is present or prove that every magnesium ion is coordinated. A physical blend containing a crystalline chelate and free glycine can produce a plausible pattern. The technique reads phases, not the fraction of the element that is chelated.
The result covers the few grams in the holder. A heterogeneous blend, a segregated drum or a sample ground differently from the reference can give a different pattern, and preferred orientation can suppress a peak that should be there. Replicate preparations and a documented sampling plan are part of a defensible result.
What it proves
- The crystalline phases present, identified against a diffraction database.
- Whether crystalline magnesium oxide is present above the method's stated detection limit.
- The expected diffraction pattern of the chelate, when a reference lot is available.
- A phase check that can be reported alongside the elemental and ligand assays.
What it does not prove
- Amorphous or nanocrystalline oxide, and oxide below the detection limit.
- The quantity of the chelate itself when it is poorly crystalline.
- Coordination, free glycine or the molar ratio.
- Heterogeneity beyond the small sample in the holder.
What to ask the laboratory
- What is the detection limit for magnesium oxide in this matrix, and how was it established?
- Which two-theta range was scanned, and what radiation was used?
- Was the sample back-loaded or pressed, and how was preferred orientation controlled?
- Is the result a phase identification, a Rietveld quantification or a spiked calibration?
Read the detection limit before you read the word absent. A screen reported at 1% w/w and a screen reported at 5% w/w answer different questions, even when both say no oxide detected. Check the scan range, the sample preparation, whether a spiked calibration was run, and whether the result is a phase identification or a quantified limit. Pair it with magnesium and glycine figures before drawing a conclusion about the form.
Where the method is used
- Magnesium Bisglycinate — 1:2 magnesium–glycine chelate, anhydrous basis.
Sources
The method pages sit behind the COA page. The terms used here are defined in the buyer glossary, and the regulatory limits are on the compliance page.
Related documents
Send the certificate or specification you are reviewing and we will name the method behind each figure.
Request a specification review